Lingti Kong

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Cerebrospinal Fluid

Drug Administration

Ejection Fraction

Acinetobacter Baumannii

Top Venues

European journal of clinical pharmacology

British journal of clinical pharmacology

Analytical methods : advancing methods and applications

Infection and drug resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyuan Xie, Manxue Jiang, Jian Xu, Yulin Zhu, Lingti Kong
Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study. Journal of chemotherapy (Florence, Italy) (2024)
Li Rong, Mengyuan Xie, Manxue Jiang, Hongyu Qiu, Lingti Kong
A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2023)
Mengyuan Xie, Manxue Jiang, Hongyu Qiu, Li Rong, Lingti Kong
Optimization of Voriconazole Dosing Regimens Against Aspergillus Species and Candida Species in Pediatric Patients After Hematopoietic Cell Transplantation: A Theoretical Study Based on Pharmacokinetic/Pharmacodynamic Analysis. Journal of clinical pharmacology (2023)
Li Rong, Mengyuan Xie, Manxue Jiang, Hongyu Qiu, Lingti Kong
A post-marketing pharmacovigilance study of avapritinib: adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2023)
Li Rong, Mengyuan Xie, Manxue Jiang, Hongyu Qiu, Lingti Kong
A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2023)
Yongli Wei, He Zhang, Maowu Fu, Rui Ma, Ronghui Li, Lingti Kong
Plasma and Intrapulmonary Pharmacokinetics, and Dosage Regimen Optimization of Linezolid for Treatment of Gram-Positive Cocci Infections in Patients with Pulmonary Infection After Cerebral Hemorrhage. Infection and drug resistance 15 (2022)
Xiaohong Qin, Lingti Kong, Chenchen Wu, Xiaohua Zhang, Meng Xie, Xiaofei Wu
Pharmacokinetic/pharmacodynamic analysis of high-dose tigecycline, by Monte Carlo simulation, in plasma and sputum of patients with hospital-acquired pneumonia. Journal of clinical pharmacy and therapeutics (2022)
Linhu Ye, Lei Cheng, Lingti Kong, Xinqian Zhao, Guoyan Xie, Jing He, Hong Liu, Yan Deng, Xinyu Wu, Tingting Wang, Xixiao Yang
Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation. Analytical methods : advancing methods and applications 14 (11) (2022)
Lingti Kong, Jian Xu, Qingping Shi, Lei Li
Pharmacokinetics of imipenem in both plasma and peritoneal draining liquid in elder patients with perforated upper gastrointestinal tract. European journal of clinical pharmacology 76 (9) (2020)
Liang Meng, Lingti Kong, Chenchen Wu, Benquan Qi, Xiaofei Wu
Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains. European journal of clinical pharmacology 76 (1) (2019)
Lingti Kong, Hongzhou Xu, Chenchen Wu, Xuguang Zhao, Xiaofei Wu
Pharmacokinetics of imipenem in plasma and cerebrospinal fluid in patients with intracerebral hemorrhage. European journal of clinical pharmacology 74 (9) (2018)
Hongzhou Xu, Lingti Kong, Chenchen Wu, Bo Xu, Xiaofei Wu
Pharmacokinetics of meropenem in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after lateral ventricle drainage. European journal of clinical pharmacology 75 (4) (2018)